Brief: Evoke Pharma Reports Second Quarter 2022 Financial Results
10/08/2022 21:19
Aug 10 (Reuters) - Evoke Pharma Inc EVOK.O :
* EVOKE PHARMA REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
* EVOKE PHARMA - BELIEVES EXISTING CASH & CASH EQUIVALENTS,
AND
FUTURE CASH FLOWS FROM NET PRODUCT SALES OF GIMOTI, WILL FUND
OPERATIONS INTO Q2 2023
* EVOKE PHARMA INC - QTRLY LOSS PER SHARE $0.71
Source text for Eikon: ID:nGNX5Y8wZq
Further company coverage: EVOK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evoke Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary